As of February 19, 2025, the average one-year price target for Candel Therapeutics is $17.34/share. The forecasts range from a low of $15.15 to a high of $19.95. The average price target ...
Fintel reports that on February 7, 2025, B of A Securities initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a Buy recommendation. As of January 29, 2025, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback